
|Articles|April 15, 2003
B&L wins extended range on laser; delays implant application
Rochester, NY-On the same day Bausch & Lomb celebrated FDA approval of a larger treatment range for its Technolas 217A excimer laser system, it said it would delay a year before asking the FDA to approve its Retisert drug-delivery implant.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Development of maculopathy associated with systemic medications
2
STAAR postpones Alcon merger vote, Broadwood calls for removal of board members
3
FDA issues Complete Response Letter to Sydnexis for SYD-101 pediatric myopia treatment
4
Proactive strategies and sustained delivery advance glaucoma care
5

















































.png)


